Rahmani Maryam, Nili Fatemeh, Tabibian Elnaz
Department of Radiology, Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Imam Khomeini Hospital Complex (IKHC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Department of Pathology, Imam Khomeini Hospital Complex (IKHC), Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Am J Case Rep. 2018 Apr 27;19:494-499. doi: 10.12659/AJCR.907638.
BACKGROUND There are few reports of breast cancer cases with uterine metastases; among them, myometrium is more frequently involved than endometrium. The majority of breast cancer metastases to endometrium are lobular type, and there have been only 5 reported cases of ductal type since 1984. Here, we describe a new case of invasive ductal carcinoma with metastases to endometrium and isolated presentation of abnormal uterine bleeding, in addition to reviewing the existing literature on other similar cases. CASE REPORT The patient was a 51-year-old Persian woman with no remarkable past medical or family history of cancer, who presented with a 6-month complaint of menorrhagia to our gynecology clinic. Diagnostic studies including trans-vaginal ultrasonography, pathological examination of endometrial curettage specimen, immunohistochemistry findings, and X-plane and magnetic resonance mammography, and breast core-needle biopsy revealed invasive ductal breast carcinoma as the origin of the endometrial metastasis. CONCLUSIONS Abnormal uterine bleeding in a premenopausal patient should alert clinicians to the possibility of secondary as well as primary neoplasms. It is necessary to differentiate a metastatic tumor from a primary one, since the treatment and prognosis are completely different.
关于乳腺癌子宫转移病例的报道较少;其中,子宫肌层受累比子宫内膜更常见。大多数乳腺癌转移至子宫内膜的为小叶型,自1984年以来,仅报道过5例导管型。在此,我们描述1例浸润性导管癌转移至子宫内膜并以子宫异常出血为孤立表现的新病例,并回顾其他类似病例的现有文献。病例报告:患者为一名51岁的波斯女性,既往无明显癌症病史或家族癌症史,因月经过多6个月前来我们的妇科诊所就诊。包括经阴道超声检查、子宫内膜刮宫标本病理检查、免疫组化结果、X线和磁共振乳腺造影以及乳腺粗针活检在内的诊断性研究显示,浸润性导管乳腺癌是子宫内膜转移的起源。结论:绝经前患者出现子宫异常出血应提醒临床医生注意继发性和原发性肿瘤的可能性。区分转移性肿瘤和原发性肿瘤很有必要,因为治疗和预后完全不同。